The Hutchison China Meditech share price – where next?
The Hutchison China Meditech (LON:HCM) share price has risen by 13.7% over the past month and it’s currently trading at 418.72. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.
According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Hutchison China Meditech currently has:
- 1 Buy recommendations
- 1 Hold recommendations
- 0 Sell recommendations
This suggests that analysts are generally positive about the outlook.
Going beyond analyst recommendations
At its current price of 418.72, shares in Hutchison China Meditech are trading at a discount of -16.5% to its 52 week high price. The 1-year performance of the shares has been -12.7%.
While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Hutchison China Meditech it's worth doing some investigation yourself.
While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of HUTCHMED (China) it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with HUTCHMED (China) that you can find out about here.
About us
Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.